Profil
Alan F.
Joslyn formerly worked at Oragenics, Inc., as President, Chief Executive Officer & Director from 2016 to 2021, Mt.
Cook Pharma, Inc., as President & Chief Executive Officer from 2007 to 2009, Sentinella Pharmaceuticals, Inc., as Chief Executive Officer & Director from 2010 to 2014, Edusa Pharmaceuticals, Inc., as President, Chief Executive Officer & Director from 2010 to 2012, GlaxoSmithKline Research & Development, as Director in 1995, Synergy Pharmaceuticals LLC, as Independent Director from 2009 to 2019, Johnson & Johnson, as Vice President-Global Drug Development, Penwest Pharmaceuticals Co., as Senior Vice President-Research & Development from 2004 to 2007, Care Capital LLC, as Executive in Residence, and Lazarus Pharmaceuticals, LLC, as Partner.
Dr. Joslyn received his doctorate degree in 1986 from State University of New York at Buffalo and undergraduate degree in 1981 from State University of New York at Buffalo.
Anciens postes connus de Alan Joslyn
| Sociétés | Poste | Fin |
|---|---|---|
| ORAGENICS, INC. | Directeur Général | 02/05/2021 |
| SYNERGY PHARMACEUTICALS INC | Directeur/Membre du Conseil | 01/05/2019 |
Sentinella Pharmaceuticals, Inc.
Sentinella Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur Général | 01/04/2014 |
Edusa Pharmaceuticals, Inc.
Edusa Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops biotechnology products for the treatment of gastrointestinal disorders | Directeur Général | 01/10/2012 |
Mt. Cook Pharma, Inc.
Mt. Cook Pharma, Inc. Pharmaceuticals: MajorHealth Technology Provides treatments for urological diseases | Directeur Général | 01/03/2009 |
Formation de Alan Joslyn
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Johnson & Johnson
Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Penwest Pharmaceuticals Co.
Penwest Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Oragenics, Inc.
Oragenics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel antibiotics and treatments against infectious disease and oral mucositis | Health Technology |
Mt. Cook Pharma, Inc.
Mt. Cook Pharma, Inc. Pharmaceuticals: MajorHealth Technology Provides treatments for urological diseases | Health Technology |
Care Capital LLC
Care Capital LLC Investment ManagersFinance Care capital invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and specialty pharmaceuticals. It provides financing for growth and buyout capital transactions with an investment size of USD 5 - 20 million. | Finance |
State University of New York at Buffalo
State University of New York at Buffalo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline Research & Development
GlaxoSmithKline Research & Development Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Synergy Pharmaceuticals LLC
Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops drugs to treat gastrointestinal disorders and diseases | Health Technology |
Sentinella Pharmaceuticals, Inc.
Sentinella Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Edusa Pharmaceuticals, Inc.
Edusa Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops biotechnology products for the treatment of gastrointestinal disorders | Health Technology |
Lazarus Pharmaceuticals, LLC
Lazarus Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Operates as a clinical stage pharmaceutical development company | Health Technology |
















